Comparing AIMS65 Score With MEWS, qSOFA Score, Glasgow-Blatchford Score, and Rockall Score for Predicting Clinical Outcomes in Cirrhotic Patients With Upper Gastrointestinal Bleeding

比较AIMS65评分与MEWS、qSOFA评分、格拉斯哥-布拉奇福德评分和罗卡尔评分在预测肝硬化合并上消化道出血患者临床结局方面的效能

阅读:1

Abstract

BACKGROUND: The aim of our study was to compare the Age 65; International normalized ratio; Mental status; Shock (AIMS65) score with the Modifi ed Early Warning Score (MEWS), quick Sepsis Related Organ Failure Assessment (qSOFA) score, Glasgow-Blatchford score (GBS), and the complete Rockall score (CRS) in predicting clinical outcomes in cirrhotic patients with upper gastrointestinal bleeding (UGIB). METHODS: A total of 442 consecutive cirrhotic patients admitted with UGIB during a 17-month period were retrospectively investigated. The primary outcome was in-hospital mortality. The secondary outcomes were rebleeding, intensive care unit (ICU) admission and development of infection. The area under receiver operating characteristic curve (AUC) for each system was analyzed. RESULTS: For prediction of mortality, the AUC of the AIMS65 score was greater than that of other scoring systems without statistical signifi cance. For the prediction of rebleeding, the AIMS65 score was superior to qSOFA (0.65 vs. 0.56, p = 0.020). For the prediction of ICU admission, the AIMS65 score was superior to the GBS and CRS (0.77 vs. 0.63, p = 0.005 and 0.77 vs. 0.63, p = 0.007, respectively). For the prediction of the development of infection, the AIMS65 score was superior to CRS (0.73 vs. 0.60, p = 0.010). CONCLUSIONS: In predicting in-hospital mortality among cirrhotic patients with UGIB, the AIMS65 score showed a trend of better performance than the MEWS, qSOFA score, GBS, and CRS. The AUCs of the AIMS65 score were greater than other four systems in predicting rebleeding, ICU admission and the development of infection.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。